Skip to main content
Livermore
Livermore
ZHEN

Shufro Rose & Co LLC

SEC CIK
0000908195
Latest filing
Aug 12, 2026

The latest 13F from Shufro Rose & Co LLC covers Q2 2026 (filed Aug 12, 2026): 311 long positions worth $1.74B. The top 10 holdings make up 49.4% of the portfolio, and the largest is iShares Ibonds Dec 2029 Term Corporate ETF at 11.6%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
26
Est. +$34.9M
Added
61
Est. +$143.7M
Reduced
120
Est. −$89.5M
Sold out
19
Est. −$8.77M

Top 5 holdings

Share of this quarter's portfolio value

  1. iShares Ibonds Dec 2029 Term Corporate ETF46436E205
    11.6%$200.8M
  2. GLWCorning Inc
    8.2%$143.4MHistory
  3. Alps ETF Tr00162Q346
    7.8%$136.4M
  4. Doubleline ETF Trust25861R303
    4.7%$81.3M
  5. iShares Core S&P 500 ETF464287200
    3.8%$65.9M

Share of portfolio

Top 5 holdings and the other 306 positions, by share of portfolio value

  1. iShares Ibonds Dec 2029 Term Corporate ETF11.6%
  2. GLW8.2%
  3. Alps ETF Tr7.8%
  4. Doubleline ETF Trust4.7%
  5. iShares Core S&P 500 ETF3.8%
  6. Other 306 positions63.9%

Biggest buys

New and added positions, by estimated amount bought

  1. iShares Ibonds Dec 2029 Term Corporate ETF46436E205
    +$108.6MAdded
  2. Invesco Exch TRD SLF Idx FD46138J460
    +$25.7MNew
  3. OUNZVanEck Merk Gold ETF
    +$10.3MAddedHistory
  4. Alps ETF Tr00162Q346
    +$4.97MAdded
  5. iShares Ibonds Dec 2030 Term Corporate ETF46436E726
    +$3.46MAdded

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. iShares Ibonds Dec 2029 Term Corporate ETF46436E205
    +5.25 pp6.3% → 11.6%
  2. Invesco Exch TRD SLF Idx FD46138J460
    +1.48 pp0.0% → 1.5%
  3. OUNZVanEck Merk Gold ETF
    +0.29 pp1.1% → 1.4%History
  4. iShares Ibonds Dec 2030 Term Corporate ETF46436E726
    +0.17 pp0.2% → 0.3%
  5. MUMicron Technology Inc
    +0.15 pp0.1% → 0.2%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. iShares Ibonds Dec 2026 Term Corporate ETF46435GAA0
    −$29.5MReduced
  2. Invesco Exch TRD SLF Idx FD46138J791
    −$12.0MReduced
  3. GLWCorning Inc
    −$11.8MReducedHistory
  4. VanEck ETF Trust92189F106
    −$11.8MReduced
  5. CRMSalesforce, Inc.
    −$3.50MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. iShares Ibonds Dec 2026 Term Corporate ETF46435GAA0
    −2.02 pp2.1% → <0.1%
  2. VanEck ETF Trust92189F106
    −1.44 pp2.5% → 1.0%
  3. Invesco Exch TRD SLF Idx FD46138J791
    −0.90 pp1.4% → 0.5%
  4. MSFTMicrosoft Corp
    −0.43 pp2.8% → 2.4%History
  5. CRMSalesforce, Inc.
    −0.37 pp0.6% → 0.2%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$1.74B
+$270.7M (+18.4%) vs. prior quarter
Positions
311
+7 vs. prior quarter
Top 10 concentration
49.4%
Top 10 as share of value
Turnover
6.1%
Q2 2026, one quarter
Average holding period
15.4 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $1.74B (Q2 2026)

Q1 2021: $1.26BQ2 2021: $1.33BQ3 2021: $1.28BQ4 2021: $1.38BQ1 2022: $1.30BQ2 2022: $1.15BQ3 2022: $1.00BQ4 2022: $1.18BQ1 2023: $1.08BQ2 2023: $1.09BQ3 2023: $1.06BQ4 2023: $1.05BQ1 2024: $1.21BQ2 2024: $1.23BQ3 2024: $1.23BQ4 2024: $1.28BQ1 2025: $1.27BQ2 2025: $1.24BQ3 2025: $1.22BQ4 2025: $1.48BQ1 2026: $1.47BQ2 2026: $1.74B
Q1 2021Q2 2026
13F filings of Shufro Rose & Co LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 12, 2026311$1.74BiShares Ibonds Dec 2029 Term Corporate ETFGLWAlps ETF Trvs. Q1 2026SEC
Q1 2026May 15, 2026304$1.47BAlps ETF TriShares Ibonds Dec 2029 Term Corporate ETFGLWvs. Q4 2025SEC
Q4 2025Feb 9, 2026298$1.48BAlps ETF TriShares Ibonds Dec 2029 Term Corporate ETFDoubleline ETF Trustvs. Q3 2025SEC
Q3 2025Nov 12, 2025311$1.22BAlps ETF TriShares Ibonds Dec 2029 Term Corporate ETFiShares Core S&P 500 ETFvs. Q2 2025SEC
Q2 2025Aug 11, 2025307$1.24BAlps ETF TriShares Ibonds Dec 2029 Term Corporate ETFiShares Core S&P 500 ETFvs. Q1 2025SEC
Q1 2025May 8, 2025310$1.27BAlps ETF TriShares Ibonds Dec 2029 Term Corporate ETFiShares Core S&P 500 ETFvs. Q4 2024SEC
Q4 2024Feb 25, 2025293$1.28BiShares Ibonds Dec 2027 Term Corporate ETFETF Ser SolutionsAAPLvs. Q3 2024SEC
Q3 2024Nov 12, 2024309$1.23BiShares Ibonds Dec 2027 Term Corporate ETFETF Ser SolutionsMSFTvs. Q2 2024SEC
Q2 2024Aug 13, 2024309$1.23BiShares Ibonds Dec 2027 Term Corporate ETFETF Ser SolutionsMSFTvs. Q1 2024SEC
Q1 2024May 8, 2024310$1.21BiShares Ibonds Dec 2027 Term Corporate ETFETF Ser SolutionsMSFTvs. Q4 2023SEC
Q4 2023Feb 5, 2024302$1.05BiShares Ibonds Dec 2026 Term Corporate ETFInvesco Exch TRD SLF Idx FDMSFTvs. Q3 2023SEC
Q3 2023Oct 26, 2023304$1.06BiShares Ibonds Dec 2026 Term Corporate ETFInvesco Exch TRD SLF Idx FDMSFTvs. Q2 2023SEC
Q2 2023Aug 3, 2023312$1.09BiShares Ibonds Dec 2026 Term Corporate ETFInvesco Exch TRD SLF Idx FDMSFTvs. Q1 2023SEC
Q1 2023Apr 20, 2023317$1.08BiShares Ibonds Dec 2026 Term Corporate ETFInvesco Exch TRD SLF Idx FDInvesco Exchange Traded FD Tvs. Q4 2022SEC
Q4 2022Jan 25, 2023337$1.18BiShares TrInvesco Exch TRD SLF Idx FDiShares Ibonds Dec 2026 Term Corporate ETFvs. Q3 2022SEC
Q3 2022Oct 24, 2022330$1.00BiShares Ibonds Dec 2026 Term Corporate ETFInvesco Exchange Traded FD TTMOvs. Q2 2022SEC
Q2 2022Jul 22, 2022319$1.15BiShares Ibonds Dec 2026 Term Corporate ETFJPMorgan Ultra-Short Income ETFiShares U S ETF Trvs. Q1 2022SEC
Q1 2022May 9, 2022335$1.30BInvesco Exch TRD SLF Idx FDInvesco Exchange Traded FD TJPMorgan Ultra-Short Income ETFvs. Q4 2021SEC
Q4 2021Jan 27, 2022306$1.38BInvesco Exch TRD SLF Idx FDJPMorgan Ultra-Short Income ETFInvesco Exchange Traded FD Tvs. Q3 2021SEC
Q3 2021Nov 5, 2021297$1.28BInvesco Exch TRD SLF Idx FDJPMorgan Ultra-Short Income ETFInvesco Exchange Traded FD Tvs. Q2 2021SEC
Q2 2021Jul 28, 2021292$1.33BInvesco Exch TRD SLF Idx FDJPMorgan Ultra-Short Income ETFInvesco Exchange Traded FD Tvs. Q1 2021SEC
Q1 2021Apr 28, 2021294$1.26BJPMorgan Ultra-Short Income ETFiShares U S ETF TrGLW–SEC